基因诊断公司GeneDx Holdings（股票代码：WGS）今日盘中股价大涨5.11%，引发市场关注。
消息面上，多家华尔街机构纷纷上调了GeneDx Holdings的目标股价。其中，BTIG将目标价从140美元上调至165美元；杰富瑞将目标价从120美元上调至150美元；TD Cowen也将目标价从140美元上调至165美元。分析师普遍看好该公司在基因诊断领域的发展前景。
GeneDx Holdings专注于罕见疾病和遗传疾病的基因诊断服务。近期该公司在技术创新和市场拓展方面取得了一系列进展，这可能是分析师上调目标价的主要原因。随着精准医疗的发展，基因诊断市场前景广阔，GeneDx Holdings作为行业领先企业有望持续受益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.